The transcription factors STAT5A and STAT5B (STAT: signal transducer and activator of transcription) play a major role in the signaling events elicited by a number of growth factor and cytokine receptors. In this work, we aimed to investigate the role of STAT5 in human precursor B cell survival by introducing dominant-negative (DN) forms of STAT5A or STAT5B in the 697 pre-B cell line. All clones expressing DN forms of either transcription factor exhibited a higher spontaneous apoptotic rate that was massively enhanced upon interleukin-7 (IL-7) stimulation. This was associated with caspase 8 cleavage, mitochondrial transmembrane potential disruption and caspase 3 activation. However, the DN forms of STAT5 did not alter the expression of Bcl-2, Bax, Bcl-x, Bim, A1 and Mcl1 proteins in IL-7-stimulated cells. The pancaspase inhibitor Z-Val-Ala-Asp-fluoromylmethyl ketone partially suppressed IL-7-mediated mitochondrial transmembrane potential disruption and cell death, suggesting that IL-7 induced the death of DN STAT5 expressing 697 cells through caspase-dependent and -independent mechanisms that both require mitochondrial activation.
Introduction
The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway plays a major role in cytokine and growth factor signaling. Among the seven STAT family members, STAT5A and STAT5B, two highly related transcription factors, are significant regulators of cell proliferation and survival (Zamorano et al., 1998; Battle and Frank, 2002; Kisseleva et al., 2002) . Both regulate expression of genes involved in cell cycle progression like cyclin D1, cyclin D2 and p21 Waf1 and cell survival like Bcl-2, Bcl-x and A1 (Feldman et al., 1997; Matsumura et al., 1997; Dumon et al., 1999; Matsumura et al., 1999; Moriggl et al., 1999; Lord et al., 2000) . The stat5a/stat5b double knockout mice point to the important role of STAT5 in hematopoietic cell development (Teglund et al., 1998) . These mice lack NK and mast cells, exhibit impaired response of myeloid and erythroid progenitors to granulocyte-macrophage colony-stimulating factor and erythropoietin, respectively, and altered T cell response to interleukin-2 (IL-2) (Moriggl et al., 1999; Socolovsky et al., 1999; Kieslinger et al., 2000; Shelburne et al., 2002) . Finally, precursor B cell compartment is substantially reduced in these animals presumably due to an inability of progenitor B cells to proliferate in response to interleukin-7 (IL-7) (Sexl et al., 2000) . However, differentiation toward mature B cells seems unaffected in stat5a/stat5b gene deleted mice.
IL-7 signals through the common cytokine gamma chain (gc) and also uses a second component, the IL-7 receptor (IL-7R) a chain. Mice in which the IL-7 or IL7Ra chain or gc subunit encoding genes have been deleted exhibit a severe impairment in B (and T) cell development (Peschon et al., 1994; Cao et al., 1995; DiSanto et al., 1995; von Freeden-Jeffry et al., 1995; Fry and Mackall, 2002) . IL-7 promotes the survival and proliferation of mouse precursor B cells, and also renders these cells more sensitive to certain apoptotic signals (LeBien, 2000) . Although not essential for human B cell development, IL-7 exerts a number of effects on human precursor B cells, inducing proliferation of CD19 þ /CD34 þ progenitors (Dittel and LeBien, 1995) , enhancement of CD19 surface expression and downmodulation of rag1 and rag2 genes as well as terminal deoxynucleotidyl transferase transcripts (Wolf et al., 1993; Billips et al., 1995) .
IL-7 signaling involves a number of nonreceptor tyrosine kinase pathways, some of which require the JAK/STAT proteins, mainly the STAT5A and STAT5B transcription factors, and to a lesser extent STAT1 and STAT3 (van der Plas et al., 1996; Qin et al., 2001; Fry and Mackall, 2002) . STAT5 is also involved in the signaling pathway of the thymic stromal lymphopoietin that shares with IL-7 the IL-7Ra chain and many biological properties (Isaksen et al., 1999) . The role of STAT5A/5B in B cell development may not be restricted to its implication in cytokine signaling. Recent data have shown their possible involvement in B cell receptor (BCR) transduction signal (Karras et al., 1996) . Moreover, Bruton's tyrosine kinase, a tyrosine kinase that is activated upon BCR and pre-BCR ligation, was shown to interact with and to activate STAT5 in vitro. In keeping with these findings, XID mice exhibit impaired activation of STAT5 following BCR stimulation (Mahajan et al., 2001) . STAT5 also functionally interacts with the phosphatidylinositol 3-kinase/Akt pathway, which is implicated in the signaling cascades of some major receptors expressed by immature and mature B cells (Santos et al., 2001) . However, the role of STAT5 in human B lymphopoiesis remains unknown and the STAT5 target genes in the B cell lineage remain to be identified.
Besides their role in normal B cell development, there is a body of evidence suggesting that STAT5 activation is also incriminated in the malignant transformation of leukemic cells, including acute lymphoblastic leukemia cells of either pro-B or pre-B phenotype (GouilleuxGruart et al., 1996) . To evaluate the role of STAT5 in the proliferation and survival of human leukemic B cell precursors, we introduced dominant-negative (DN) forms of STAT5 (STAT5AD749 or STAT5BD754) in the human 697 pre-B cell line. We show herein that the expression of these STAT5 truncated forms induces apoptosis of IL-7-stimulated 697 cells. The potential mechanisms of this effect are presented and discussed.
Results

Expression of STAT5AD749 in the 697 pre-B cell line
The DN form of STAT5A, for example STAT5AD749 was introduced by electroporation in the 697 pre-B cells. This mutant was deleted in its carboxyl-terminal transactivation domain and as a consequence still binds to DNA following activation but is unable to induce the transcription of target genes (Moriggl et al., 1996) . As control, the 697 cell line was electroporated with the empty vector and selected with G418 (697neo cells). Cell screening was performed by Western blot using an antibody (Ab) raised against the SH2 domain of STAT5 recognizing the endogenous and the DN forms of STAT5 (Figure 1a) . Four subclones 697D5A1, 697D5A2, 697D5A3 and 697D5A4 were obtained from two separate transfections. Like parental 697 and 697neo cells, all subclones expressed a 94-95 kDa band corresponding to the known molecular weight of endogenous STAT5. An additional 84 kDa band corresponding to STAT5AD749 was only detected in the 697D5A1, 697D5A2, 697D5A3 and 697D5A4 cell extracts. Whereas the four different clones expressed comparable levels of endogenous STAT5 protein, expression of the DN STAT5 was lower in the 697D5A1 clone.
Both STAT5 and STAT5AD749 are phosphorylated following IL-7 activation
The activation of STAT5 and STAT5AD749 by IL-7 was next examined by immunoblot. Cell lysates from 697neo and 697D5A4 cells stimulated or not with IL-7 (10 ng/ml) for 24, 48 and 72 h were analysed by Western blot using an anti-phosphotyrosine-STAT5 Ab. As illustrated in Figure 1b , endogenous STAT5 was phosphorylated upon IL-7 stimulation in control cells (lanes 2-4). This activation was clearly observed at 24 h, decreased at 48 h and was nearly undetectable after 72 h. Phosphorylation of both endogenous and truncated STAT5 in 697D5A4 cells was detected after IL-7 stimulation but remained stable for up to 72 h ( Figure 1b, lanes 6-8) . Similar results were obtained with 697D5A1, 697D5A2 and 697D5A3 clones (data not shown).
IL-7 induces apoptosis of STAT5AD749-transfected clones
Although 697 cells are independent of IL-7 for their growth and survival, we examined the biological consequences of DN STAT5 activation in IL-7-stimulated 697 cells. The effects of IL-7 on cell growth and survival were analysed by cell counting and using the trypan blue exclusion method. IL-7 did not induce any significant changes in the proliferation and survival of parental 697 cells and 697neo cells (Figure 2a ). However, analysis of DN STAT5A expressing cells revealed an increased spontaneous cell death and induced a timedependent increase in their death rate (Figure 2) . Interestingly, the more the cells expressed STAT5AD749, the higher the IL-7-induced death rate ( Figure 2b , lanes 2, 4 and 5). In keeping with this finding, loss of the DN (Figure 3b ) of 697D5A4 cells demonstrated that pre-B cell death was due to apoptosis. We then checked whether a DN of STAT5B called STAT5BD754, which was also deleted in the COOH terminal transactivation domain, might exert the same effects as the STAT5A mutant. Two stable clones (697D5B1 and 697D5B2) expressing the mutated form of STAT5B were obtained ( Figure 4a ). As for STAT5AD749 expressing cells, IL-7-induced cell death related to an apoptotic process ( Figure 4b ).
IL-7 triggers mitochondrial transmembrane potential (DC m ) disruption, cleavage of caspase 8 and activation of caspase 3 in DN STAT5 expressing cells
To determine whether or not IL-7-mediated apoptosis proceeds through mitochondrial perturbations, we measured the DC m by staining the 697neo and 697D5A4 cells with the sensitive dye DiOC 6 (3) before and after IL-7 treatment (Table 1) . A decrease in DC m is considered as an early and irreversible step in the process of mitochondria-dependent apoptosis. Carbonyl cyanide m-chlorophenylhydrazone (CCCP), We then addressed the issue of whether some members of the Bcl-2 family were implicated in the IL-7-induced apoptosis. Expressions of Bcl-2, Bcl-x, Bax, Bim, Mcl1 and A1 were unaffected by the DN form of STAT5A (not shown). Stimulation of cells with IL-7 for up to 72 h induced an enhancement of Mcl1, Bcl-x and Bax in both 697neo and 697D5A4 cells. In addition, there were no significant changes in Bcl-2, A1 and Bim expression in neither 697neo nor 697D5A4 cells (not shown).
To determine whether IL-7-mediated apoptosis proceeds through caspase activation, the different 697 subclones were incubated with IL-7 and the cleavage of caspase 8 was analysed by Western blot using a specific mAb. We found that 48 h of stimulation with IL-7-induced cleavage of caspase 8 featured by the appearance of the p18 subunit in 697D5A2 and 697D5A4 cell extracts (Figure 5a, lanes 4 and 6) . No cleavage of caspase 8 was detected in 697neo cells stimulated or not with IL-7, nor in unstimulated 697D5A4 cells, whereas unstimulated 697D5A2 cells exhibited tiny amounts of p18. Finally, using a fluorimetric assay we showed that the caspase 3 enzymatic activity was sharply enhanced in a time-dependent manner in IL-7-stimulated 697D5A2 cells but not in 697 control cells (Figure 5b) . Identical results were found with other 697D5A and 697D5B clones (data not shown).
IL-7 mediates apoptosis through caspase-dependent and -independent pathways
To evaluate the role of caspases in IL-7-induced apoptosis, we examined the effects of the broadspectrum caspase inhibitor Z-Val-Ala-Asp-fluoromylmethyl ketone (Z-VAD.fmk) on cell viability using the trypan blue exclusion method. Z-VAD.fmk activity was assessed by analysing the Fas-mediated pathway, since 697 cells were previously shown to express Fas receptor and to undergo a caspase-mediated apoptosis upon Fas ligation (Levy et al., 1997) .
The addition of anti-Fas Ab (1 mg/ml) for 96 h resulted in a higher death rate in DN STAT5-transfected cells (76.973.7 and 41.473.2% for 697D5A4 and 697D5B2, respectively) compared to 697neo cells (32.173.9%, po0.005) (Figure 6a ). This higher sensitivity to Fas-mediated cell death occurred in the absence of modification of CD95 surface expression as assessed by flow cytometry and without variation in procaspase 8 and cFLIP protein expression by Western blot (data not shown) in unstimulated as well as in IL-7-stimulated cells. The addition of Z-VAD.fmk completely suppressed Fas-mediated cell death (Figure 6a and b, lane 6) in 697neo cells as well as in DN STAT5 expressing cells and abolished caspase 3 processing in 697D5A4 cells (Figure 6b , lane 6). In contrast, Z-VAD.fmk could only partially inhibit IL-7-mediated apoptosis in 697D5A4 or 697D5B2 cells (64 and 34% of inhibition, respectively). Moreover, IL-7-induced caspase 3 cleavage was abrogated by Z-VAD.fmk as demonstrated by Western blot analysis (Figure 6b ) and by fluorimetric assay (not shown) in spite of persisting cell death (42% with IL-7 versus 21% with IL-7 þ Z-VAD.fmk at 72 h using the 697D5A4 clone). These data suggest that IL-7-induced cell death in DN STAT5 expressing cells involved caspase-dependent and -independent mechanisms. Finally, we examined whether mitochondria were implicated in these mechanisms, by measuring the DC m in IL-7-stimulated 697neo, 697D5A4 and 697D5B1 cells, treated or not with Z-VAD.fmk. For this purpose, cells were stained with the sensitive dye DiOC 6 (3) and analysed by flow cytometry (Table 2) . Z-VAD.fmk could only partially restore the fall in the DC m observed in IL-7-stimulated 697D5A4 and 697D5B1 cells, whereas it totally abrogated DC m disruption in Fas-stimulated cells either in control or in DN STAT5 expressing cells. Altogether, these results suggest the participation of mitochondria in both caspase-dependent and -independent pathway-mediated apoptosis.
Discussion
To investigate the role of STAT5A and STAT5B in the survival of leukemic pre-B cell, a DN form of each transcription factor (STAT5AD749 and STAT5BD754) was introduced in the human 697 pre-B cell line. In this model, IL-7-induced phosphorylation of both truncated and wild-type forms of STAT5A or 5B and promoted apoptosis of cells expressing DN forms of these transcription factors.
The activation of the various forms of STAT5 upon IL-7 incubation was first examined. The kinetics of STAT5 phosphorylation were different between control and transfected cells. In particular, phosphorylation of STAT5AD749 and also of endogenous STAT5 was found to be more robust during the time course of IL-7 stimulation in transfected cells. This is in keeping with previous works showing that deletion of the transactivation domain of STAT5 increases the stability of the phosphorylated protein (Moriggl et al., 1996; Wang et al., 2000) . Our data indicate that expression of the DN STAT5 in 697 cells also affects the stability of phosphorylated endogenous STAT5.
The expression of DN forms of STAT5A or STAT5B has previously been shown to affect the survival of various cell types (Mui et al., 1996; Dumon et al., 1999; Lord et al., 2000; Ahonen et al., 2003) . In addition, deletion of stat5 genes in mouse can also disturb the survival and maturation of myeloid and erythroid progenitors cultured in the presence of granulocytemacrophage colony-stimulating-factor and erythropoietin (Socolovsky et al., 1999; Kieslinger et al., 2000) . Stat5a/b À/À precursor B cells were also found to have a reduced capacity to proliferate in response to IL-7 (Sexl et al., 2000) ; however, one cannot rule out the possibility that they were also insensitive to the survival signal provided by this cytokine. Indeed, IL-7 was shown to promote both proliferation and survival of normal precursor B cells, mainly those expressing the pre-BCR (LeBien, 2000; Fry and Mackall, 2002 ) and our present data clearly suggest that STAT5A/5B may be required for the survival signal mediated by IL-7. The mechanisms by which STAT5 promotes cell survival usually involve the antiapoptotic Bcl-2, Bcl-x and A1 proteins (Feldman et al., 1997; Dumon et al., 1999; Lord et al., 2000) . However, our results indicate that Bcl-x, Bcl-2 and A1 were not implicated in the IL-7-induced death of 697 cells expressing the DN forms of STAT5. The expression of Mcl1, another antiapoptotic molecule Caspases, a family of cysteine proteases, constitute potent enzymatic machinery that cleaves crucial proteins of the nucleus and the cytoplasm and may lead to apoptosis (Cohen, 1997) . Caspase and Bid cleavage (not shown) was significantly enhanced by IL-7, indicating the implication of a caspase-dependent pathway in IL-7-induced apoptosis of DN expressing cells. This is reminiscent of the recent report of caspases 3 and 9 activation in mast cells derived from the bone marrow of Stat5-deficient mice, exposed to IL-3 and SCF (Shelburne et al., 2002) . These results and ours indicate that loss of STAT5 function triggers caspase activation via so far unidentified mechanisms. In most models of apoptosis, the broad-spectrum caspase inhibitor Z-VAD.fmk blocks cell death by irreversibly inhibiting the activation or processing of caspases (Komoriya et al., 2000) . We found herein that in 697 cells expressing DN STAT5, Z-VAD.fmk only partially blocked the IL-7-mediated apoptosis, suggesting that both caspasedependent and -independent mechanisms take place in this process. An increasing number of experimental systems support the notion that programmed cell death can also proceed in a caspase-independent manner, with stereotyped features (Susin et al., 2000; Bidere and Senik, 2001) . For example, anti-CD2 mAb or staurosporine induced caspase-independent cell death in activated human peripheral T lymphocytes. These apoptosis inducers operate in the presence of broadspectrum caspase inhibitor (Deas et al., 1998) . The mitochondrial apoptosis-inducing factor (AIF) family proteins might be involved in this process (Susin et al., 1999) . Further experiments will be performed to evaluate the participation of such proteins in the apoptosis mediated by DN STAT5 in 697 pre-B cells. Interestingly, DN STAT5 expressing 697 cells were found to be more sensitive to Fasmediated cell death than controls, suggesting that STAT5 not only promotes survival of leukemic pre-B cells but also negatively regulates certain apoptotic pathways. The mechanisms involved in this enhanced sensitivity to Fas-induced apoptosis are now under investigation.
In summary, we found that 697 pre-B cells expressing DN STAT5 undergo apoptosis upon IL-7 stimulation following a caspase-dependent and -independent pathway. Our findings provide a new insight into the role of STAT5 in the survival process of 697 leukemic pre-B cells and outline the major place taken by STAT5 in the IL-7-mediated pre-B cell survival.
Materials and methods
Cell culture, electroporation and cloning
The IL-7-independent 697 human pre-B cell line (Findley et al., 1982) was maintained in RPMI 1640 supplemented with 2 mM L-glutamine and 10% heat-inactivated fetal calf serum at 371C, 5% CO 2 .
The pRSV-STAT5AD749, pRSV-STAT5BD754 or pRSVneo plasmids (Moriggl et al., 1996) were electroporated at 300 V, 975 mF in the 697 pre-B cell line (20 mg/4 Â 10 6 cells). Electroporated cells were expanded for 24 h before G418 selection (1 mg/ml). Pools of G418 resistant cells expressing STAT5AD749 or STAT5BD754 by Western blot were cloned by limited dilution.
Antibodies and reagents
The following Abs were used: anti-CD95 (CH11), anti-caspase 8 (Coulter/Immunotech, Marseille, France), anti-caspase 3 (Becton Dickinson, Pharmingen), anti-cFLIP (calbiochem, CA, USA), anti-SH2 domain of STAT5 (Transduction Laboratories, Lexington, Ky), anti-Bcl-2, anti-Bcl-x, antiMcl1, anti-Bax, anti-A1 and anti-actin (Santa Cruz Biotechnology, CA, USA), anti-Bim (Affinity BioReagents, CO, USA), anti-phosphotyrosine-STAT5 (Biolabs-Cell Signaling, Beverly-New England, USA), anti-peroxydaseconjugated Abs specific for rabbit or mouse IgG (Amersham Pharmacia biotech, England) or for goat IgG (Santa Cruz Biotechnology, CA, USA). IL-7 was purchased from Peprotech.
Analysis of cell death
The cell viability was analysed by the trypan blue exclusion assay. Briefly, 2.5 Â 10 4 cells/well were incubated as triplicates in flat bottom plates in culture medium supplemented or not with IL-7 (10 ng/ml) for 24, 48, 72 or 96 h, and the percentage of dead cells was evaluated. In some experiments, the broadspectrum caspase inhibitor Z-VAD.fmk (50 mM) (Bachem) was added alone or in combination with IL-7. Z-VAD.fmk activity was assessed by its ability to inhibit CD95-induced 697 cell death. CD95 Ab was used in the conditions described above with IL-7.
For measurement of cellular DNA content, 10 6 cells were washed in cold phosphate-buffered saline (PBS)-EDTA 5 mM, and permeabilized with 500 ml 70% ethanol PBS at À201C for 10 min. After two washes in cold PBS, cells were resuspended in PBS-EDTA 5 mM supplemented with RNase A (1.3 mg/ml, Sigma) and PI (33 mg/ml, Sigma) for 30 min at room temperature. Samples were analysed by flow cytometry (EPICS Elite Cytometer, Beckman, Coulter). Annexin-V-FITC staining was performed according to the manufacturer's instructions (Boehringer, Mannheim, Germany). The percentage of apoptotic cells was analysed by flow cytometry.
The DC m disruption was evaluated using the cationic lipophilic dye DiOC 6 (3). For this purpose, cells were washed in PBS-EDTA 5 mM, incubated for 20 min with 40 nM DiOC 6 (3) (Calbiochem) and 5 mg/ml of PI at room temperature and then immediately analysed by flow cytometry. As a positive control, cells were treated in parallel samples with the protonophore uncoupling agent CCCP 250 mM (Calbiochem) 1 h before staining with DiOC 6 (3) and PI.
